James Monroe and Lawrence Ilag of Finnegan, Henderson, Farabow, Garrett & Dunner LLP analyse the impact of the US Court of Appeals for the Federal Circuit’s decision In re Kubin.
Four years ago, the Federal Circuit held in In re Kubin, 561 F.3d 1351 (Fed. Cir. 2009) that the claimed polynucleotide (DNA) sequences in that case were obvious, although the prior art did not disclose or suggest what the claimed sequences would look like. In effect, the Federal Circuit found the sequences obvious because the prior art disclosed sufficient information to make isolating and characterising the claimed DNA sequences a rather straightforward project.
We explore in this report how the Kubin decision has informed the United States Patent and Trademark Office’s (USPTO) standard in determining obviousness of DNA fragments. In particular, we describe and analyse here the USPTO’s Patent Trial and Appeal Board’s (PTAB) recent adjudications in appeals arising from obviousness rejections of polynucleotide claims. We then reflect on how DNA patent applications may be made more robust given this legal landscape.
In Ex parte Levinson, 2013 Pat. App. LEXIS 923 (PTAB Mar. 1, 2013), the invention related to compositions generating an immune response that did not target IgE sitting on mast cells and therefore avoided potentially deleterious mast cell release reactions.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
Kubin, obviousness, DNA sequences, Hadwiger, Arnold